GlaxoSmithKline (GSK) and Qualcomm are apparently working on establishing a joint venture to develop medical technology, Bloomberg is reporting citing “people with knowledge of the matter.”
Nothing has been decided yet, and we may still be far from seeing the new company emerging. In the meantime, we know that both parties have been active in the digital health space.
Qualcomm is especially active through its Qualcomm Life division that has formed and later expanded partnership with Novartis. It has also been partnering with other players such as Cerner, AMC Health, and Roche, to name the few, offering them its 2net and HealthyCircles solutions.
GSK on its end has been teaming-up with IBM and Google to crunch health numbers and track patients taking their medicines. At one point, the pharma giant has even explored launching a ResearchKit study, and has worked with Medidata to evaluate impact of mHealth tech in clinical trials.
Unsurprisingly, representatives of each companies declined to comment…